MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whiteaker, P.
Right arrow Articles by Wonnacott, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whiteaker, P.
Right arrow Articles by Wonnacott, S.

Vol. 53, Issue 5, 950-962, May 1998

Agonist-Induced Up-Regulation of alpha 4beta 2 Nicotinic Acetylcholine Receptors in M10 Cells: Pharmacological and Spatial Definition

Paul Whiteaker,1 Christopher G. V. Sharples, and Susan Wonnacott

Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK

Chronic nicotine up-regulates the number of high affinity nicotinic acetylcholine receptors (nAChRs) in mammalian brain. Here, we studied up-regulation of the nAChR composed of alpha 4 and beta 2 subunits in the M10 cell line by using [3H]epibatidine to measure nAChR in cells in situ and in membrane preparations. Cultures were exposed to drugs for 2 days before assay. All agonists up-regulated [3H]epibatidine binding sites with EC50 values typically 10-100-fold higher than their respective Ki values from competition binding assays. Maximum up-regulation ranged from 40% to 250% above control values. Maximally effective concentrations of the less efficacious agonists methylcarbamylcholine or (±)-epibatidine together with nicotine resulted in less up-regulation than that produced by nicotine alone, showing that they are partial up-regulatory agonists. The antagonists dihydro-beta -erythroidine, methyllycaconitine, d-tubocurarine, hexamethonium, decamethonium, and mecamylamine either failed to up-regulate [3H]epibatidine binding sites or up-regulated mildly at high concentrations. When tested at non-up-regulating concentrations, only d-tubocurarine significantly inhibited agonist-induced up-regulation; this inhibition seemed to be noncompetitive. Comparison of [3H]epibatidine displacement in intact M10 cells and membrane preparations by membrane-impermeant ligands indicated that 85% of [3H]epibatidine binding sites are intracellular. On chronic treatment with agonist, the proportion of surface receptors did not change significantly, indicating that most up-regulated [3H]epibatidine binding sites are internal. However, up-regulation is mediated at the cell surface because the impermeant ligand tetramethylammonium was as efficacious as nicotine in eliciting up-regulation, and methylcarbamylcholine (i.e., impermeant but with low efficacy) blocked nicotine induced up-regulation. Thus, agonists elicit up-regulation (mainly of intracellular receptors) by interacting with cell surface nAChRs that are not compatible with either an active or high affinity desensitized conformation.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Physiol. Rev.Home page
E. X. Albuquerque, E. F. R. Pereira, M. Alkondon, and S. W. Rogers
Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
Physiol Rev, January 1, 2009; 89(1): 73 - 120.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Kishi and J. H. Steinbach
Role of the Agonist Binding Site in Up-Regulation of Neuronal Nicotinic {alpha}4beta2 Receptors
Mol. Pharmacol., December 1, 2006; 70(6): 2037 - 2044.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Person, K. L. Bills, H. Liu, S. K. Botting, J. Lindstrom, and G. B. Wells
Extracellular Domain Nicotinic Acetylcholine Receptors Formed by {alpha}4 and {beta}2 Subunits
J. Biol. Chem., December 2, 2005; 280(48): 39990 - 40002.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Kuryatov, J. Luo, J. Cooper, and J. Lindstrom
Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human {alpha}4{beta}2 Acetylcholine Receptors
Mol. Pharmacol., December 1, 2005; 68(6): 1839 - 1851.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. B. Ficklin, S. Zhao, and G. Feng
Ubiquilin-1 Regulates Nicotine-induced Up-regulation of Neuronal Nicotinic Acetylcholine Receptors
J. Biol. Chem., October 7, 2005; 280(40): 34088 - 34095.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. F. Vallejo, B. Buisson, D. Bertrand, and W. N. Green
Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism
J. Neurosci., June 8, 2005; 25(23): 5563 - 5572.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. B. Free, S. B. McKay, P. D. Gottlieb, R. T. Boyd, and D. B. McKay
Expression of Native {alpha}3{beta}4* Neuronal Nicotinic Receptors: Binding and Functional Studies Investigating Turnover of Surface and Intracellular Receptor Populations
Mol. Pharmacol., June 1, 2005; 67(6): 2040 - 2048.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Darsow, T. K. Booker, J. C. Pina-Crespo, and S. F. Heinemann
Exocytic Trafficking Is Required for Nicotine-induced Up-regulation of {alpha}4{beta}2 Nicotinic Acetylcholine Receptors
J. Biol. Chem., May 6, 2005; 280(18): 18311 - 18320.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. D. Li, J. Beuten, J. Z. Ma, T. J. Payne, X.-Y. Lou, V. Garcia, A. S. Duenes, K. M. Crews, and R. C. Elston
Ethnic- and gender-specific association of the nicotinic acetylcholine receptor {alpha}4 subunit gene (CHRNA4) with nicotine dependence
Hum. Mol. Genet., May 1, 2005; 14(9): 1211 - 1219.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Bibevski and M. E. Dunlap
Prevention of diminished parasympathetic control of the heart in experimental heart failure
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1780 - H1785.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Y. Lopez-Hernandez, J. Sanchez-Padilla, A. Ortiz-Acevedo, J. Lizardi-Ortiz, J. Salas-Vincenty, L. V. Rojas, and J. A. Lasalde-Dominicci
Nicotine-induced Up-regulation and Desensitization of {alpha}4{beta}2 Neuronal Nicotinic Receptors Depend on Subunit Ratio
J. Biol. Chem., September 3, 2004; 279(36): 38007 - 38015.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Sallette, S. Bohler, P. Benoit, M. Soudant, S. Pons, N. Le Novere, J.-P. Changeux, and P. J. Corringer
An Extracellular Protein Microdomain Controls Up-regulation of Neuronal Nicotinic Acetylcholine Receptors by Nicotine
J. Biol. Chem., April 30, 2004; 279(18): 18767 - 18775.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. L. Parker, Y. Fu, K. McAllen, J. Luo, J. M. McIntosh, J. M. Lindstrom, and B. M. Sharp
Up-Regulation of Brain Nicotinic Acetylcholine Receptors in the Rat during Long-Term Self-Administration of Nicotine: Disproportionate Increase of the {alpha}6 Subunit
Mol. Pharmacol., March 1, 2004; 65(3): 611 - 622.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. R. Baker, R. Zwart, E. Sher, and N. S. Millar
Pharmacological Properties of {alpha}9{alpha}10 Nicotinic Acetylcholine Receptors Revealed by Heterologous Expression of Subunit Chimeras
Mol. Pharmacol., February 1, 2004; 65(2): 453 - 460.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Nashmi, M. E. Dickinson, S. McKinney, M. Jareb, C. Labarca, S. E. Fraser, and H. A. Lester
Assembly of {alpha}4{beta}2 Nicotinic Acetylcholine Receptors Assessed with Functional Fluorescently Labeled Subunits: Effects of Localization, Trafficking, and Nicotine-Induced Upregulation in Clonal Mammalian Cells and in Cultured Midbrain Neurons
J. Neurosci., December 17, 2003; 23(37): 11554 - 11567.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
W. Fu and J. H. Jhamandas
{beta}-Amyloid Peptide Activates Non-{alpha}7 Nicotinic Acetylcholine Receptors in Rat Basal Forebrain Neurons
J Neurophysiol, November 1, 2003; 90(5): 3130 - 3136.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. E. Nelson, A. Kuryatov, C. H. Choi, Y. Zhou, and J. Lindstrom
Alternate Stoichiometries of alpha 4beta 2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., February 1, 2003; 63(2): 332 - 341.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. L. Gentry, L. H. Wilkins Jr., and R. J. Lukas
Effects of Prolonged Nicotinic Ligand Exposure on Function of Heterologously Expressed, Human alpha 4beta 2- and alpha 4beta 4-Nicotinic Acetylcholine Receptors
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 206 - 216.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. C. Harkness and N. S. Millar
Changes in Conformation and Subcellular Distribution of alpha 4beta 2 Nicotinic Acetylcholine Receptors Revealed by Chronic Nicotine Treatment and Expression of Subunit Chimeras
J. Neurosci., December 1, 2002; 22(23): 10172 - 10181.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. L. Meyer, Y. Xiao, and K. J. Kellar
Agonist Regulation of Rat alpha 3beta 4 Nicotinic Acetylcholine Receptors Stably Expressed in Human Embryonic Kidney 293 Cells
Mol. Pharmacol., September 1, 2001; 60(3): 568 - 576.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Buisson and D. Bertrand
Chronic Exposure to Nicotine Upregulates the Human {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Function
J. Neurosci., March 15, 2001; 21(6): 1819 - 1829.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. Narahashi, C. P. Fenster, M. W. Quick, R. A. J. Lester, W. Marszalec, G. L. Aistrup, D. B. Sattelle, B. R. Martin, and E. D. Levin
Symposium Overview: Mechanism of Action of Nicotine on Neuronal Acetylcholine Receptors, from Molecule to Behavior
Toxicol. Sci., October 1, 2000; 57(2): 193 - 202.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. G. V. Sharples, S. Kaiser, L. Soliakov, M. J. Marks, A. C. Collins, M. Washburn, E. Wright, J. A. Spencer, T. Gallagher, P. Whiteaker, et al.
UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the alpha 4beta 2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes
J. Neurosci., April 15, 2000; 20(8): 2783 - 2791.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. G. Mukhin, D. Gündisch, A. G. Horti, A. O. Koren, G. Tamagnan, A. S. Kimes, J. Chambers, D. B. Vaupel, S. L. King, M. R. Picciotto, et al.
5-Iodo-A-85380, an alpha 4beta 2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors
Mol. Pharmacol., March 1, 2000; 57(3): 642 - 649.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. Hukovic, M. Rocheville, U. Kumar, R. Sasi, S. Khare, and Y. C. Patel
Agonist-dependent Up-regulation of Human Somatostatin Receptor Type 1 Requires Molecular Signals in the Cytoplasmic C-tail
J. Biol. Chem., August 27, 1999; 274(35): 24550 - 24558.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. P. Fenster, T. L. Whitworth, E. B. Sheffield, M. W. Quick, and R. A. J. Lester
Upregulation of Surface alpha 4beta 2 Nicotinic Receptors Is Initiated by Receptor Desensitization after Chronic Exposure to Nicotine
J. Neurosci., June 15, 1999; 19(12): 4804 - 4814.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
G. Gambassi, R. Bernabei, A. V. Prochazka, and M. J. Weaver
Antidepressants and Smoking Cessation
Arch Intern Med, June 14, 1999; 159(11): 1257 - 1258.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. C. Perry, M. I. Dávila-García, C. A. Stockmeier, and K. J. Kellar
Increased Nicotinic Receptors in Brains from Smokers: Membrane Binding and Autoradiography Studies
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1545 - 1552.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics